Lipocine Announces Initiation Of Phase 3 BLOOM Study Of Oral Brexanolone LPCN 1154 In Postpartum Depression, Planning About 120 Participants; First Dosing Expected Early Q4 2026

Benzinga Newsdesk www.benzinga.com Neutral 56.3%

Neg 0% Neu 56.3% Pos 0%

Comments

No comments yet. Be the first!